This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The bill is sponsored by Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.).
"Today's passage of S. 483 by the House marks the final step in the legislative process before the bill goes to President Obama's desk for his signature. HDMA commends Senators Hatch and Whitehouse as well as Reps. Marino, Blackburn, Welch and Chu - and their respective staffs - for their steady leadership as the legislation worked its way through both chambers. S. 483 establishes common-sense policies that will bring together supply chain stakeholders and regulators to address prescription drug abuse in a more transparent and collaborative way.
"More than three years ago, HDMA's pharmaceutical distributor members created the initial concept that later became the bill that was passed today. It has been gratifying to watch as the primary framework, initially advocated by our industry, and supported by patient, pharmacy and provider groups, gained champions in the House and Senate and evolved into full-fledged legislation that ultimately garnered bipartisan support. Following President Obama's signing of the bill, HDMA will continue to work with our members, regulators and supply chain partners, to ensure that the legislation delivers on its promise."
